Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 2;12(6):925.
doi: 10.3390/jpm12060925.

Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice

Affiliations
Review

Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice

Federica Invernizzi et al. J Pers Med. .

Abstract

Autoimmune liver diseases (AILDs) include autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis. The etiologies of AILD are not well understood but appear to involve a combination of genetic and environmental factors. AILDs commonly affect young individuals and are characterized by a highly variable clinical course. These diseases significantly influence quality of life and can progress toward liver decompensation or the onset of hepatocellular or cholangiocarcinoma; a significant number of patients eventually progress to end-stage liver disease, requiring liver transplantation. In this review, we focus on the sex characteristics and peculiarities of AILD patients and highlight the relevance of a sex-specific analysis in future studies. Understanding the sex differences underlying AILD immune dysregulation may be critical for developing more effective treatments.

Keywords: autoimmune hepatitis primary biliary cirrhosis; autoimmune liver diseases; gender; liver transplant; overlap syndromes; primary sclerosing cholangitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Factors responsible for gender differences in immune response.

References

    1. Czaja A.J., Manns M.P. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology. 2010;139:58–72.e4. doi: 10.1053/j.gastro.2010.04.053. - DOI - PubMed
    1. Bogdanos D.P., Choudhuri K., Vergani D. Molecular mimicry and autoimmune liver disease: Virtuous intentions, malign consequences. Liver. 2001;21:225–232. doi: 10.1034/j.1600-0676.2001.021004225.x. - DOI - PubMed
    1. Coss Adame E., Granados J., Uribe M., Torre A. Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (AIH-PBC) from those with auto-immune hepatitis type 1? Ann. Hepatol. 2011;10:28–32. - PubMed
    1. Manns M.P., Czaja A.J., Gorham J.D., Krawitt E.L., Mieli-Vergani G., Vergani D., Vierling J.M. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–2219. doi: 10.1002/hep.23584. - DOI - PubMed
    1. Gregorio G.V., Portmann B., Reid F., Donaldson P.T., Doherty D.G., McCartney M., Mowat A.P., Vergani D., Milei-Vergani G. Autoimmune hepatitis in childhood: A 20-year experience. Hepatology. 1997;25:541–547. doi: 10.1002/hep.510250308. - DOI - PubMed

LinkOut - more resources